Skip to main content
. 2010 Oct 6;48(12):4604–4607. doi: 10.1128/JCM.01143-10

TABLE 2.

Susceptibility rates of 30 blaKPC-possessing E. coli isolates according to the 2009 and 2010 CLSI breakpoints

Breakpoint yr % susceptiblea
Broth microdilution method
Etest method
IPM MER DOR ETP IPM MER DOR ETP
2009 77 77 17b 43 47 80 17b 47
2010 3 40 50 0 3 43 23 0
a

IPM, imipenem; MER, meropenem; DOR, doripenem; ETP, ertapenem.

b

Values calculated based on the 2009 FDA-recommended breakpoint for doripenem.